5.2.2025 08:10:03 CET | Demant A/S |
Indkaldelse til generalforsamling
Indkaldelse til generalforsamling
Til aktionærerne i
Demant A/S 5. februar 2025
Der indkaldes herved til ordinær generalforsamling i Demant A/S
torsdag den 6. marts 2025 kl. 15.00
på selskabets adresse
Kongebakken 9, 2765 Smørum
Før generalforsamlingen vil der fra kl. 14.15 blive serveret kaffe og kage.
Den ordinære generalforsamling vil blive afholdt som et fysisk møde og afvikles på dansk.
Generalforsamlingen kan følges live via webcast på selskabets hjemmeside, www.demant.com, fra kl. 15.00. Webcast vil kun omfatte podie og talerstol.
Se nedenfor for yderligere informationer om deltagelse i generalforsamlingen.
Dagsorden
I overensstemmelse med vedtægternes pkt. 8.2 er dagsordenen følgende:
1. Bestyrelsens beretning for selskabets virksomhed i det forløbne år.
Bestyrelsen indstiller til generalforsamlingen, at beretningen tages til efterretning.
2. Fremlæggelse af revideret Annual Report 2024 (årsrapport for 2024), herunder koncernregnskab, til godkendelse.
Bestyrelsen indstiller årsrapporten for 2024 til godkendelse.
3. Beslutning om anvendelse af overskud eller dækning af underskud i henhold til den godkendte årsrapport for 2024.
Bestyrelsen foreslår, at overskuddet på DKK 1.658 mio. overføres til selskabets reserver, således at der ikke udbetales udbytte.
4. Fremlæggelse af og vejledende afstemning om Remuneration Report 2024 (vederlagsrapporten for 2024).
5. Godkendelse af vederlag til bestyrelsen for indeværende regnskabsår.
Bestyrelsen indstiller det foreslåede vederlag til godkendelse.
6. Valg af bestyrelsesmedlemmer.
I henhold til vedtægternes pkt. 11.2 vælges de generalforsamlingsvalgte bestyrelsesmedlemmer for ét år ad gangen. På den ordinære generalforsamling i 2025 stiller Niels B. Christiansen, Niels Jacobsen, Sisse Fjelsted Rasmussen og Kristian Villumsen op til genvalg. Bestyrelsen stiller forslag om valg af Katrin Pucknat som nyt bestyrelsesmedlem.
7. Valg af revision.
Bestyrelsen foreslår genvalg af PwC. Bestyrelsen foreslår tillige genvalg af PwC til afgivelse af erklæring med begrænset sikkerhed om bæredygtighedsrapportering i ledelsesberetningen.
8. Eventuelle forslag fra bestyrelse eller aktionærer.
Bestyrelsen har fremsat følgende forslag:
8a) Nedsættelse af selskabets aktiekapital
8b) Bemyndigelse til bestyrelsen til at lade selskabet erhverve egne aktier
8c) Bemyndigelse til generalforsamlingens dirigent
9. Eventuelt.
Uddybning af forslagene
Ad dagsordenens pkt. 4
Bestyrelsen foreslår, at generalforsamlingen godkender vederlagsrapporten for 2024. Vederlagsrapporten kan findes på selskabets hjemmeside, https://www.demant.com/investor-relations/annual-general-meeting.
Afstemningen er vejledende i medfør af selskabslovens § 139 b, stk. 4.
Vederlagsrapporten for 2023 blev godkendt på den ordinære generalforsamling den 6. marts 2024 uden kommentarer fra aktionærerne.
Ad dagsordenens pkt. 5
Bestyrelsen foreslår, at grundhonoraret for bestyrelsesmedlemmer forbliver DKK 450.000 for 2025, og at det fastholdes, at formanden modtager tre gange grundhonoraret og næstformanden to gange grundhonoraret.
Bestyrelsen foreslår endvidere, at grundhonoraret for revisionsudvalgets medlemmer forbliver DKK 100.000 for 2025, og at det fastholdes, at revisionsudvalgets formand modtager to gange grundhonoraret.
Ad dagsordenens pkt. 6
Niels B. Christiansen, Niels Jacobsen, Sisse Fjelsted Rasmussen og Kristian Villumsen er på genvalg. Bestyrelsen foreslår valg af Katrin Pucknat som nyt bestyrelsesmedlem. For så vidt angår oplysninger om de enkelte bestyrelseskandidaters ledelseshverv m.v., kan følgende oplyses:
Niels B. Christiansen, bestyrelsesformand (født i 1966, mand, dansk). Indtrådt i bestyrelsen i 2008. Senest genvalgt i 2024 for ét år. Formand for nominerings- og vederlagsudvalget. Anses ikke som uafhængigt medlem af bestyrelsen, da han er næstformand i William Demant Fonden (selskabets hovedaktionær). Øvrige ledelseshverv: LEGO A/S, adm. direktør og koncernchef; LEGO Holding, direktør; William Demant Fonden, næstformand; William Demant Invest A/S, bestyrelsesmedlem; Tetra Laval S.A, bestyrelsesmedlem og Dansk Industri, formand for erhvervspolitisk udvalg.
Niels B. Christiansen er civilingeniør fra DTU og har en MBA fra INSEAD. Han har bred og international ledelseserfaring fra store, globale, højteknologiske forbrugsvare- og industrivirksomheder. Dertil kommer omfattende bestyrelseserfaring fra børsnoterede virksomheder samt omfattende indsigt i erhvervspolitik og bæredygtighed/ESG.
Niels Jacobsen, næstformand (født i 1957, mand, dansk). Indtrådt i bestyrelsen i 2017. Senest genvalgt i 2024 for ét år. Medlem af nominerings-, vederlags- og revisionsudvalget. Anses ikke som uafhængigt medlem af bestyrelsen, da han som adm. direktør for William Demant Invest A/S har tilknytning til William Demant Fonden (selskabets hovedaktionær). Øvrige ledelseshverv: William Demant Invest A/S, adm. direktør; Thomas B. Thriges Fond, bestyrelsesformand; ABOUT YOU Holding GmbH, næstformand; ATP Long Term Danish Capital, medlem af Advisory Board. Derudover har Niels Jacobsen ledelseshverv relateret til William Demant Invest: Jeudan A/S, bestyrelsesformand; Embla Medical hf., bestyrelsesformand og Vision Rt Ltd., bestyrelsesformand.
Niels Jacobsen er cand.oecon fra Aarhus Universitet. Han har betydelig ledelseserfaring fra store internationale virksomheder. Hans kompetencer inkluderer både virksomhedsledelse og dybtgående viden om finansielle forhold, regnskab, risikostyring samt M&A. Han har bred erfaring inden for global healthcare.
Sisse Fjelsted Rasmussen (født i 1967, kvinde, dansk). Indtrådt i bestyrelsen i 2021. Senest genvalgt i 2024 for ét år. Formand for revisionsudvalget. Anses som uafhængigt medlem af bestyrelsen. Øvrige ledelseshverv: Hempel Fonden, bestyrelsesmedlem; Schouw & Co., bestyrelsesmedlem; Dades A/S, bestyrelsesmedlem og Conscia A/S, bestyrelsesmedlem.
Sisse Fjelsted Rasmussen er statsautoriseret revisor og cand.merc.aud. fra Copenhagen Business School. Hun har omfattende erfaring med og kompetencer inden for finans og regnskab og har derudover stor ledelses- og bestyrelseserfaring fra børsnoterede selskaber samt kompetencer inden for værdiskabelse, forandringsledelse, M&A samt bæredygtighed/ESG.
Kristian Villumsen (født i 1970, mand, dansk). Indtrådt i bestyrelsen i 2021. Senest genvalgt i 2024 for ét år. Medlem af revisionsudvalget. Anses som uafhængigt medlem af bestyrelsen. Øvrige ledelseshverv: Coloplast A/S, koncernchef og adm. direktør og Dansk Industri, medlem af Life Science-udvalget.
Kristian Villumsen er cand.scient.pol. fra Aarhus Universitet og har en MA i Public Policy fra Harvard University i USA. Han har betydelig international ledelseserfaring fra medicoindustrien samt stor ledelses- og bestyrelseserfaring fra børsnoterede virksomheder, herunder inden for innovation, salg, strategiimplementering samt commercial excellence.
Katrin Pucknat (født i 1976, kvinde, tysk). Foreslået som nyt bestyrelsesmedlem. Hun vil blive anset som uafhængigt medlem af bestyrelsen. Øvrige ledelseshverv: ResMed Inc., Chief Marketing Officer og Consumer Sleep Solutions LLC, bestyrelsesmedlem.
Katrin Pucknat har en BSc i Business Marketing fra University of Phoenix, USA. Hun har betydelig international erfaring inden for generel ledelse fra medicoindustrien samt omfattende ledelseserfaring inden for marketing, salg, produktinnovation og digital transformation af virksomheder.
Ad dagsordenens pkt. 7
Bestyrelsen foreslår genvalg af PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab (PwC) i overensstemmelse med revisionsudvalgets indstilling. Bestyrelsen foreslår tillige genvalg af PwC til afgivelse af erklæring med begrænset sikkerhed om bæredygtighedsrapportering i ledelsesberetningen. Revisionsudvalget er ikke blevet påvirket af tredjeparter og har ikke været underlagt nogen aftale med en tredjepart, som begrænser generalforsamlingens valg af visse revisorer eller revisionsfirmaer.
Ad dagsordenens pkt. 8a
Bestyrelsen foreslår nedsættelse af selskabets aktiekapital med nominelt DKK 1.459.025,80 fordelt på 7.295.129 stk. aktier a DKK 0,20 svarende til selskabets beholdning af egne aktier pr. 4. februar 2025 fraregnet aktier til dækning af ledende medarbejderes og direktionens aktiebaserede fastholdelsesprogram. Selskabets beholdning af egne aktier er for størstedelens vedkommende erhvervet som led i selskabets aktietilbagekøb i 2024. Nedsættelsesbeløbet anvendes til udbetaling til aktionærerne, jf. selskabslovens § 188. Aktierne er erhvervet for i alt DKK 2.199.603.564,00, således at der ud over det nominelle nedsættelsesbeløb har været udbetalt DKK 2.198.144.538,20.
Som konsekvens af kapitalnedsættelsen foreslås vedtægternes pkt. 4.1 ændret tilsvarende efter udløbet af den i selskabslovens § 192, stk. 1, angivne frist, således at det herefter af pkt. 4.1 vil fremgå, at selskabets aktiekapital udgør DKK 42.758.932,60.
Inden kapitalnedsættelsen gennemføres, vil selskabets kreditorer via Erhvervsstyrelsens it-system blive opfordret til at anmelde deres krav inden for en frist på fire uger, jf. selskabslovens § 192, stk. 1. Gennemførelse af kapitalnedsættelsen og den deraf følgende ændring af vedtægterne vil blive registreret som endelig hos Erhvervsstyrelsen efter udløbet af fristen for kreditorers anmeldelse af krav, jf. selskabslovens § 193, stk. 1, medmindre gennemførelse af kapitalnedsættelsen på dette tidspunkt ikke kan finde sted efter selskabslovens bestemmelser.
Ad dagsordenens pkt. 8b
Bestyrelsen foreslår, at bestyrelsen indtil næste ordinære generalforsamling bemyndiges til at lade selskabet erhverve egne aktier med en pålydende værdi af indtil 10 % af aktiekapitalen. Købskursen for de pågældende aktier må på tidspunktet for erhvervelsen ikke afvige mere end 10 % fra den noterede kurs på Nasdaq Copenhagen A/S.
Ad dagsordenens pkt. 8c
Generalforsamlingens dirigent bemyndiges til at foretage sådanne ændringer i og tilføjelser til det på generalforsamlingen vedtagne samt anmeldelsen heraf til Erhvervsstyrelsen, som Erhvervsstyrelsen måtte kræve i forbindelse med registrering af de vedtagne ændringer.
* * * * * *
Vedtagelse af forslaget under dagsordenens pkt. 8a (nedsættelse af selskabets aktiekapital) kræver, at mindst 51 % af aktiekapitalen er repræsenteret på generalforsamlingen, og at beslutningen tiltrædes af mindst 2/3 af såvel de afgivne stemmer som den repræsenterede, stemmeberettigede aktiekapital, jf. vedtægternes pkt. 10.3.
De øvrige forslag på dagsordenen kan vedtages med simpelt flertal, jf. vedtægternes pkt. 10.2. Dog er afstemningen under dagsordenens pkt. 4 vederlagsrapporten for 2024 alene vejledende.
Selskabets aktiekapital udgør DKK 44.217.958,40 fordelt på aktier a DKK 0,20 eller multipla heraf, jf. vedtægternes pkt. 4.1. Hvert aktiebeløb på DKK 0,20 giver én stemme, jf. vedtægternes pkt. 9.1.
Deltagelse, adgangskort og stemmerettigheder
Møde- og stemmeret tilkommer i henhold til vedtægternes pkt. 9.2 aktionærer, som på registreringsdatoen, 27. februar 2025, er noteret som aktionær i ejerbogen eller på dette tidspunkt har rettet henvendelse til selskabet med henblik på notering i ejerbogen, og denne henvendelse er modtaget af selskabet.
En aktionær med møde- og stemmeret i henhold til vedtægternes pkt. 9.2 er berettiget til at møde på generalforsamlingen, når vedkommende senest den 3. marts 2025 kl. 23.59 dansk tid har rekvireret adgangskort til sig selv og en eventuel medfølgende rådgiver.
Der gøres opmærksom på, at man kun kan deltage i generalforsamlingen, hvis man er noteret i ejerbogen på registreringsdatoen og har rekvireret adgangskort forud for generalforsamlingen.
Adgangskort kan rekvireres:
Elektronisk på aktionærportalen (Shareholder Portal), som bl.a. kan findes på selskabets hjemmeside, https://www.demant.com/investor-relations/shareholder-portal,
ved fremsendelse af bestillingsblanket pr. brev til Computershare A/S, Lottenborgvej 26 D, 1. sal, 2800 Kgs. Lyngby, eller ved fremsendelse af indscannet bestillingsblanket pr. e-mail til gf@computershare.dk,
ved skriftlig henvendelse til selskabets kontor, Kongebakken 9, 2765 Smørum (mrk: “Adgangskort til generalforsamling”), eller
ved personlig henvendelse på selskabets adresse, Kongebakken 9, 2765 Smørum.
Selskabet vil derefter sende elektronisk adgangskort pr. e-mail til den e-mailadresse, der er angivet i aktionærportalen ved tilmeldingen. Adgangskortet skal medbringes til generalforsamlingen enten elektronisk på smartphone/tablet eller udskrevet. Opstår der fejl med det elektroniske adgangskort, eller er det ikke muligt at modtage adgangskortet elektronisk eller udskrive det selv, skal adgangskort afhentes ved ankomst til generalforsamlingen mod forevisning af behørig legitimation.
Aktionærer vil få udleveret fysiske stemmesedler ved ankomst til generalforsamlingen.
Selskabet har udpeget Danske Bank A/S som kontoførende bank, hvorigennem selskabets aktionærer kan udøve deres økonomiske rettigheder.
* * * * * *
Information på selskabets hjemmeside
Senest den 12. februar 2025 offentliggøres følgende oplysninger og dokumenter på selskabets hjemmeside, https://www.demant.com/investor-relations/annual-general-meeting: 1) indkaldelse til generalforsamlingen, 2) det samlede antal aktier og stemmerettigheder på datoen for indkaldelsen, 3) de dokumenter, der skal fremlægges på generalforsamlingen, herunder revideret årsrapport for 2024 og vederlagsrapporten for 2024, 4) dagsorden for generalforsamlingen og de fuldstændige forslag og 5) formularer til stemmeafgivelse ved brev og fuldmagt.
Skriftlige spørgsmål
Som aktionær kan du skriftligt stille spørgsmål vedrørende dagsordenen og dokumenter til brug for generalforsamlingen. Hvis du har spørgsmål, kan disse fremsendes pr. post til selskabet eller pr. e-mail til info@demant.com. Fremsendte spørgsmål vil blive besvaret skriftligt før generalforsamlingen eller mundtligt i forbindelse med generalforsamlingen, medmindre svaret inden da fremgår af selskabets hjemmeside, https://www.demant.com/investor-relations/annual-general-meeting.
Afgivelse af fuldmagt
Såfremt du er forhindret i at deltage i generalforsamlingen, vil selskabets bestyrelse gerne modtage fuldmagt til at afgive de stemmer, der er tilknyttet dine aktier. Fuldmagt afgives elektronisk på aktionærportalen (Shareholder Portal), som blandt andet kan findes på selskabets hjemmeside, https://www.demant.com/investor-relations/shareholder-portal, senest den 3. marts 2025 kl. 23.59 dansk tid. Du kan også udfylde, datere og underskrive en fuldmagtsblanket og fremsende den pr. brev til Computershare A/S, Lottenborgvej 26 D, 1. sal, 2800 Kgs. Lyngby, eller fremsende en indscannet fuldmagtsblanket pr. e-mail til gf@computershare.dk, således at den er modtaget senest den 3. marts 2025 kl. 23.59 dansk tid. Ønsker du at give fuldmagt til andre end selskabets bestyrelse, kan du give fuldmagt til tredjemand. Du skal endvidere rekvirere adgangskort til den befuldmægtigede. Den nævnte fuldmagtsblanket kan findes på selskabets hjemmeside, https://www.demant.com/investor-relations/annual-general-meeting.
Afgivelse af brevstemme
Endvidere har du mulighed for at brevstemme. Brevstemme afgives elektronisk på aktionærportalen (Shareholder Portal), som blandt andet kan findes på selskabets hjemmeside, https://www.demant.com/investor-relations/shareholder-portal, senest den 5. marts 2025 kl. 12.00. Du kan også udfylde, datere og underskrive en brevstemmeblanket, der er den samme blanket som fuldmagtsblanketten, og fremsende den pr. brev til Computershare A/S, Lottenborgvej 26 D, 1. sal, 2800 Kgs. Lyngby, eller fremsende en indscannet brevstemmeblanket pr. e-mail til gf@computershare.dk, således at den er modtaget senest den 5. marts 2025 kl. 12.00. Brevstemmeblanket kan findes på selskabets hjemmeside, https://www.demant.com/investor-relations/annual-general-meeting.
Webcast
Generalforsamlingen kan følges live via webcast på selskabets hjemmeside, www.demant.com, fra kl. 15.00. Vi gør opmærksom på, at det ikke er muligt at deltage aktivt i generalforsamlingen, dvs. stille spørgsmål eller stemme, hvis man følger generalforsamlingen via webcast. Da generalforsamlingen er offentligt tilgængelig via webcast på selskabets hjemmeside, skal man ikke registrere sig eller bestille adgangskort for at følge med her.
Webcast vil kun omfatte podie og talerstol.
Persondata
I forbindelse med generalforsamlingen indsamler, behandler og opbevarer selskabet visse personoplysninger. For yderligere information henvises til selskabets privatlivspolitik, som er tilgængelig på selskabets hjemmeside, https://www.demant.com/privacy-notice.
Smørum, den 5. februar 2025
Bestyrelsen
Om Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.
Vedhæftninger
2025-03 Indkaldelse til generalforsamling.pdf
5.2.2025 08:10:03 CET | Demant A/S |
Notice to general meeting
Notice of Annual General Meeting
To the shareholders of
Demant A/S 5 February 2025
Notice is hereby given of the Annual General Meeting (AGM) of Demant A/S
Thursday, 6 March 2025 at 3:00 p.m. CET
at the company’s headquarters
Kongebakken 9, 2765 Smørum, Denmark
Before the AGM, coffee and cake will be served from 2:15 p.m. CET.
The AGM will be held as a physical meeting and will be conducted in Danish.
Please note that the entire AGM will be webcast on the company’s website, www.demant.com, from 3:00 p.m. CET. The webcast will only cover podium and lectern.
Please see below for further information on how to attend the AGM.
Agenda
In accordance with Article 8.2 of the Articles of Association, the agenda is as follows:
1. The Board of Directors’ report on the company’s activities in the past year.
The Board of Directors recommends that the report is noted.
2. Presentation for approval of the audited Annual Report 2024, including the consolidated financial statements.
The Board of Directors recommends that the Annual Report 2024 is approved.
3. Resolution on the appropriation of profit or payment of loss according to the approved Annual Report 2024.
The Board of Directors proposes that the profit of DKK 1,658 million is transferred to the company’s reserves to the effect that no dividend is paid.
4. Presentation of and indicative vote on Remuneration Report 2024.
5. Approval of remuneration for the Board of Directors for the current financial year.
The Board of Directors recommends that the proposed remuneration is approved.
6. Election of members to the Board of Directors.
Under Article 11.2 of the Articles of Association, Board members elected by the AGM are elected for one-year terms. At the AGM in 2025, Niels B. Christiansen, Niels Jacobsen, Sisse Fjelsted Rasmussen and Kristian Villumsen stand for re-election. The Board proposes that Katrin Pucknat is elected as a new member of the Board.
7. Election of auditor.
The Board of Directors proposes re-election of PwC. The Board of Directors also proposes re-election of PwC to provide an opinion on the limited assurance of sustainability reporting in the management statement.
8. Any proposals from the Board of Directors or shareholders.
The Board of Directors has submitted the following proposals:
8a) Reduction of the company’s share capital
8b) Authorisation to the Board of Directors to let the company acquire own shares
8c) Authority to the chair of the AGM
9. Any other business.
Elaboration on the proposals
Re agenda item 4
The Board of Directors proposes that Remuneration Report 2024 is approved. The Report is available on the company’s website, https://www.demant.com/investor-relations/annual-general-meeting.
The vote is indicative pursuant to section 139b (4) of the Danish Companies Act.
Remuneration Report 2023 was approved at the AGM on 6 March 2024 without comments from the shareholders.
Re agenda item 5
The Board of Directors proposes that the basic fee for Board members remains at DKK 450,000 for 2025 and that the Chair receives three times the basic fee and the Vice Chair twice the basic fee.
In addition to this, the Board of Directors proposes that the basic fee for audit committee members remains at DKK 100,000 for 2025 and that the chair of the audit committee receives twice the basic fee.
Re agenda item 6
Niels B. Christiansen, Niels Jacobsen, Sisse Fjelsted Rasmussen and Kristian Villumsen stand for re-election. The Board of Directors proposes that Katrin Pucknat is elected as a new member of the Board of Directors. Information on each of the Board members, their managerial positions etc. follows below:
Niels B. Christiansen, Chair (born in 1966, man, Danish). Joined the Board of Directors in 2008. Most recently re-elected in 2024 for a term of one year. Chair of the nomination and remuneration committees. He is not considered independent because of his seat as vice chair on the board of William Demant Foundation (the company’s majority shareholder). Other managerial positions: LEGO A/S, CEO and President; LEGO Holding, CEO; William Demant Foundation, vice chair; William Demant Invest A/S, board member; Tetra Laval S.A., board member and Confederation of Danish Industry, chair of the Committee on Business Policy.
Niels B. Christiansen holds an MSc in Engineering from the Technical University of Denmark (DTU) and holds an MBA from INSEAD. He has broad and international leadership experience from major, global, high-tech, consumer goods and industrial enterprises. In addition, he has extensive board experience from listed companies as well as extensive insight into industrial policy and sustainability/ESG.
Niels Jacobsen, Vice Chair (born in 1957, man, Danish). Joined the Board of Directors in 2017. Most recently re-elected in 2024 for a term of one year. He is a member of the audit, nomination and remuneration committees. He is not considered independent, as he, in his capacity as CEO of William Demant Invest A/S, is associated with William Demant Foundation (the company’s main shareholder). Other managerial positions: William Demant Invest A/S, CEO; Thomas B. Thriges Fond (Thomas B. Thrige Foundation), chair; ABOUT YOU Holding GmbH, vice chair; ATP Long Term Danish Capital, member of Advisory Board. Related to William Demant Invest: Jeudan A/S, chair; Embla Medical hf., chair and Vision RT Ltd., chair.
Niels Jacobsen holds an MSc in Economics from Aarhus University. He has substantial leadership experience from major international companies. His competencies include both business management and in-depth knowledge of financial matters, accounting, risk management and M&A. He has broad experience from the global healthcare industry.
Sisse Fjelsted Rasmussen (born in 1967, woman, Danish). Joined the Board of Directors in 2021 and was most recently re-elected in 2024 for a term of one year. She is chair of the audit committee. She is considered independent. Other managerial positions: Hempel Foundation, board member; Schouw & Co., board member; Dades A/S, board member; Conscia A/S, board member.
Sisse Fjelsted Rasmussen is a state-authorised public accountant and holds an MSc in Business Administration and Auditing from Copenhagen Business School (CBS). She has extensive experience with and competencies in finance and accounting. In addition, she has extensive management and board experience from listed companies as well as competencies within value creation, change management, M&A and sustainability/ESG.
Kristian Villumsen (born in 1970, man, Danish). Joined the Board of Directors in 2021. Most recently re-elected in 2024 for a term of one year. Member of the audit committee. He is considered independent. Other managerial positions: Coloplast, President & CEO and Confederation of Danish Industry, member of the Committee on Healthcare Issues.
Kristian Villumsen holds an MSc in Political Science from Aarhus University and an MA in Public Policy from Harvard University. He has significant international management experience from the MedTech industry as well as extensive management and board experience from listed companies within innovation, sale, strategy deployment and commercial excellence.
Katrin Pucknat (born in 1976, woman, German). Proposed as new Board member. She will be considered independent. Other managerial positions: ResMed Inc., Chief Marketing Officer and Consumer Sleep Solutions LLC, board member.
Katrin Pucknat holds a BSc in Business Marketing from University of Phoenix, USA. She has significant international general management experience from the MedTech industry as well as extensive management experience within marketing, sale, product innovation and digital business transformation.
Re agenda item 7
The Board proposes that PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab (PwC) is re-elected in accordance with the recommendation of the audit committee. The Board also proposes that PwC is re-elected to provide an opinion on the limited assurance of sustainability reporting in the management review. The audit committee has not been influenced by any third party and has not been subject to any agreements concluded with third parties that limit the election by the AGM of certain auditors or accounting firms.
Re agenda item 8a
The Board of Directors proposes a reduction of the company’s share capital by nominally DKK 1,459,025.80, divided into 7,295,129 shares of DKK 0.20, corresponding to the company’s holding of treasury shares as at 4 February 2025 less shares to cover sharebased retention programmes for senior leadership and the Executive Board. The company’s holding of treasury shares is, for the most part, acquired as part of the company’s share buy-backs in 2024. The amount of the reduction will be distributed to the shareholders in accordance with section 188 of the Danish Companies Act. The shares were acquired at a total price of DKK 2,199,603,564.00, meaning that in addition to the nominal amount of the reduction, DKK 2,198,144,538.20 was paid.
As a result of the capital reduction, the Board of Directors proposes that Article 4.1 of the Articles of Association is amended accordingly after expiry of the time limit prescribed in section 192 (1) of the Danish Companies Act to the effect that it will then be stated in Article 4.1 that the company’s share capital is DKK 42,758,932.60.
Before the capital reduction is implemented, the company’s creditors will, through the IT system of the Danish Business Authority (Erhvervsstyrelsen), be requested to file their claims within four weeks in accordance with section 192 (1) of the Danish Companies Act. Under section 193 (1) of the Danish Companies Act, the capital reduction and the resulting amendment of the company’s Articles of Association will be registered as final by the Danish Business Authority four weeks after expiry of the time limit for the filing of claims by creditors, unless the capital reduction cannot be implemented at such time under the provisions of the Danish Companies Act.
Re agenda item 8b
The Board of Directors proposes that, until the next AGM, the Board is authorised to let the company acquire own shares of a nominal value of up to 10% of the share capital. The purchase price for the shares must at the time of purchase not deviate by more than 10% from the price quoted on Nasdaq Copenhagen A/S.
Re agenda item 8c
The chair of the AGM is authorised to make any such amendments and additions to the resolutions passed by the AGM and to apply for registration of such amendments and additions with the Danish Business Authority that may be required by the Authority in connection with the registration of the amendments passed.
* * * * * *
Adoption of the proposed resolution under agenda item 8a (reduction of the company’s share capital) is subject to at least 51% of the share capital being represented at the AGM and the resolution being passed by at least two‐thirds of both the votes cast and the voting share capital represented at the AGM, cf. Article 10.3 of the Articles of Association.
The other proposed resolutions on the agenda may be passed by a simple majority of votes, cf. Article 10.2 of the Articles of Association. However, the proposed voting under agenda item 4 (Remuneration Report 2024) is solely indicative.
The company’s share capital is DKK 44,217,958.40, divided into shares of DKK 0.20 or multiples hereof, cf. Article 4.1 of the Articles of Association. Each share of DKK 0.20 carries one vote, cf. Article 9.1 of the Articles of Association.
Participation, admission cards and voting rights
Under Article 9.2 of the Articles of Association, shareholders who are registered as shareholders in the register of shareholders on the date of registration, 27 February 2025, or have made a request to be registered in the register of shareholders, and such request has reached the company, are entitled to attend and vote at the AGM.
Shareholders entitled to attend and vote at the AGM under Article 9.2 of the Articles of Association are entitled to attend the AGM, subject to having obtained an admission card for themselves and for any adviser accompanying them to the meeting no later than 3 March 2025 at 11:59 p.m. CET.
Please note that only shareholders who are registered in the register of shareholders on the date of registration and who have obtained an admission card prior to the AGM are entitled to attend.
Admission cards may be obtained:
electronically through the Shareholder Portal, which can be found on the company’s website, https://www.demant.com/investor-relations/shareholder-portal,
by submitting the order form by post to Computershare A/S, Lottenborgvej 26 D, 1. sal, DK 2800 Kgs. Lyngby, Denmark, or by submitting a scanned copy of the order form by e-mail to gf@computershare.dk,
by making a written application to the company’s headquarters, Kongebakken 9, DK-2765 Smørum, Denmark (marked “Adgangskort til generalforsamling”), or
by appearing in person at the company’s headquarters, Kongebakken 9, DK-2765 Smørum, Denmark.
The company will then send an electronic admission card by e-mail to the e-mail address indicated by the shareholder when registering via the Shareholder Portal. To gain access to the AGM, the admission card must be presented either electronically on a smartphone/tablet or as a hardcopy. If an error occurs with the electronic admission card, or if it is not possible to receive the admission card electronically or to print it, the admission card must be picked up upon arrival at the AGM against presentation of appropriate identification.
Shareholders will receive physical voting papers upon arrival at the AGM.
The company has designated Danske Bank A/S as its custodian bank through which the company’s shareholders may exercise their financial rights.
* * * * * *
Information on the company’s website
No later than 12 February 2025, the following information and documents will be made available on the company’s website, https://www.demant.com/investor-relations/annual-general-meeting: 1) Notice convening the AGM, 2) the total number of shares and voting rights as at the date of the notice, 3) the documents to be submitted to the AGM, including the audited Annual Report 2024 and Renumeration Report 2024, 4) agenda and complete proposals to be submitted to the AGM, and 5) postal and proxy voting forms.
Written questions
As a shareholder, you may submit written questions about the agenda and the documents to be used for the AGM. Any questions must be sent by post to the company or by e-mail to info@demant.com. Questions will be answered in writing before the AGM or orally at the AGM, unless the answer is made available on the company’s website, https://www.demant.com/investor-relations/annual-general-meeting, prior to the AGM.
Submission of proxy
If you are unable to attend the AGM, the company’s Board of Directors would be pleased to act as proxy to cast the votes attached to your shares. Proxies may be appointed electronically through the Shareholder Portal on the company’s website, https://www.demant.com/investor-relations/shareholder-portal, no later than 3 March 2025 at 11.59 p.m. CET. You may also complete, date and sign a proxy form and return it by post to Computershare A/S, Lottenborgvej 26 D, 1. sal, 2800 Kgs. Lyngby, Denmark, or return a scanned copy of the proxy form by e-mail to gf@computershare.dk, which must be in Computershare’s possession no later than 3 March 2025 at 11.59 p.m. CET. If you wish to appoint a proxy other than the Board of Directors, you may appoint a third-party proxy. Please note that you must also request an admission card for the proxy. The proxy form is available on the company’s website, https://www.demant.com/investor-relations/annual-general-meeting.
Submission of postal votes
You may also vote by post. Postal votes may be cast electronically through the Shareholder Portal on the company’s website, https://www.demant.com/investor-relations/shareholder-portal, no later than 5 March 2025 at 12:00 noon CET. You may also complete, date and sign a postal voting form, which is the same form as the proxy form, and return it by post to Computershare A/S, Lottenborgvej 26 D, 1. sal, 2800 Kgs. Lyngby, Denmark, or return a scanned copy of the voting form by e-mail to gf@computershare.dk, which must be in Computershare’s possession no later than 5 March 2025 at 12:00 noon CET. The postal voting form is available on the company’s website, https://www.demant.com/investor-relations/annual-general-meeting.
Webcast
The AGM will be webcast on the company’s website, www.demant.com, from 3:00 p.m. Please note that it is not possible to participate actively in the AGM and ask questions or vote, if you follow the AGM via webcast. As the AGM is publicly accessible via webcast on the company’s website, you are not required to register or request an admission card to attend the meeting.
The webcast will only cover the podium and lectern.
Personal data
In connection with the AGM, the company collects, processes and keeps certain personal data. For further information, please refer to the company’s Privacy Notice, which is available on the company’s website, https://www.demant.com/privacy-notice.
Smørum, 5 February 2025
The Board of Directors
About Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.
Attachments
2025-03 Notice to annual general meeting.pdf
